novo nordisk glp 1 oral US FDA accepts Nordisk's application for Wegovy for weight loss First Oral GLP-1 WEIGHT LOSS

However, weight loss with these drugs also could lower risk for obesity-related cancers

We discuss the use of glucagon-like peptide-1 (GLP-1) analogues as monotherapy and unimolecular dual or triple agonists that exploit the GLP-1 receptor and/or the gastric inhibitory peptide (GIP) receptor and/or the glucagon receptor

Learn what research says, expert opinions, and the benefits of incorporating cinnamon into your diet.

Whether you're taking Ozempic, Wegovy, Mounjaro, or another GLP-1 medication

GLP-1 receptor agonists can trigger heartburn and reflux in some patients by slowing stomach emptying and increasing intragastric pressure

Stopping GLP-1 therapy after reaching your weight loss goal requires careful planning